Does conversion to sirolimus as primary immunosuppression attenuate the progression of allograft vasculopathy after cardiac transplantation?
Substituting CNI with SRL as primary immunosuppression attenuates cardiac allograft vasculopathy progression.
It is feasible to recruit and train laypersons to administer selected osteopathic manual therapy techniques with fidelity. Longitudinal studies on this concept are needed to examine patient outcomes and to evaluate the retention and fidelity of laypersons over time.